ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,580.01
0.59%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) Noticias

HROW Harrow Inc

18.00
0.06 (0.33%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Harrow Inc HROW NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.06 0.33% 18.00 23:00:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
17.80 17.02 18.2075 17.97 17.94
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/6/202407:00BWMelt Pharmaceuticals Announces First Patient Dosed in..
05/6/202406:00BWHarrow Announces 52-Week Data from VEVYE® ESSENCE-2..
15/5/202406:00BWHarrow to Present at Two Investor Conferences in May
13/5/202415:01BWHarrow Announces First Quarter 2024 Financial Results
13/5/202406:00BWHarrow Names Greg DiPasquale as Senior Vice President, Head..
25/4/202406:00BWHarrow Will Release First Quarter 2024 Financial Results..
02/4/202407:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
20/3/202406:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
19/3/202416:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
19/3/202406:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
06/3/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202406:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
21/2/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202418:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:15EDGAR2Form 8-K - Current report
15/2/202415:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
09/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202415:30EDGAR2Form 8-K - Current report
29/1/202414:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202406:00BWHarrow Announces New Appointments to its Board of Directors
11/1/202406:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
09/1/202409:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202407:00EDGAR2Form 8-K - Current report
03/1/202406:15BWMelt Pharmaceuticals Provides Corporate Update
03/1/202406:00BWHarrow Partners with Leading Healthcare Market Access..
29/11/202306:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
20/11/202306:00BWHarrow to Present at Two Investor Conferences in November
16/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:34EDGAR2Form 8-K - Current report
13/11/202315:01BWHarrow Announces Third Quarter 2023 Financial Results
03/11/202315:52EDGAR2Form 8-K - Current report
30/10/202307:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
24/10/202306:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
29/9/202315:01EDGAR2Form 8-K - Current report
29/9/202307:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
26/9/202307:00BWMelt Pharmaceuticals Announces Exclusive Development and..
20/9/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:05EDGAR2Form 8-K - Current report
09/8/202315:01BWHarrow Announces Second Quarter 2023 Financial Results
31/7/202306:00BWHarrow Launches VIGAMOX® in the U.S.
26/7/202308:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
21/7/202315:02EDGAR2Form 8-K - Current report
20/7/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202318:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Su Consulta Reciente

NASDAQ
HROW
Harrow
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados